Background

Dr. B. J. Bormann, PhD has been President at Neurokine Pharmaceuticals Inc since February 05, 2015. Dr. Bormann also serves as the Interim Chief Executive Officer of Supportive Therapeutics, LLC. Dr. Bormann served as Chief Executive Officer of Harbour Antibodies. Dr. Bormann served as Chief Business Officer of NanoMedical Systems, Inc. She served as Senior Vice President, Worldwide Head of Therapeutic Alliances and Strategic Partnerships and Senior Vice President of ... Business Development and Licensing at Boehringer Ingelheim Pharmaceuticals Inc from 2007 to 2013. She was responsible for global scouting and evaluation of new partnership opportunities, as well as various business structures, including acquisitions, alliances, joint ventures and equity stakes. She is a professional with almost 30 years of experience in academic and pharmaceutical science and biotech and pharmaceutical business development. From 1996 to 2007, she served in a number of positions at Pfizer, Inc., and served as Vice President of Pfizer Global Research and Development and the world-wide Head of Strategic Alliances. Before joining Boehringer, Dr. Bormann held a number of senior positions at Pfizer, including Vice President, Strategic Alliances. Dr. Bormann has served, and continues to serve, on several boards, including the Executive Board of the Connecticut Business and Industry Association, Rincon Pharmaceuticals, Supportive Therapeutics, Institute for Pediatric Innovation and the Biotechnology Industrial Organization (BIO). In addition, she has served as a strategic consultant to Paperboy Ventures, ACG & Associates, and Atlas Venture. Dr. Bormann has been a Director at BioLineRx, Ltd since August 2013. She has been Director of Neurokine Pharmaceuticals Inc since February 05, 2015. She served as a Director and Member of Health Section Governing Board at Biotechnology Industry Organization (BIO). She worked as a research affiliate in the Department of Pathology at the Yale University School of Medicine. Dr. Bormann earned a B.S. in Biology and Chemistry from Fairfield University and received her Ph.D. in Biomedical Science from the University of Connecticut Health Center in the Department of Pathology. Dr. Bormann completed postdoctoral training at Yale Medical School in the department of pathology.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.